1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with clobetasol in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (clobetasol) | Trials (clobetasol) | Recent Studies (post-2010) (clobetasol) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,532 | 389 | 593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barlow, R; Barr, RM; Courtney, P; Greaves, MW; Judge, MR; Kobza Black, A; Lawlor, F; Mallet, AI | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and clobetasol
| Article | Year |
|---|---|
Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Arachidonic Acid; Blister; Clobetasol; Dinoprostone; Exudates and Transudates; Female; Gas Chromatography-Mass Spectrometry; Humans; Lipid Metabolism; Male; Middle Aged; Platelet Activating Factor; Skin | 1993 |